pancillin 500.000 ie filmovertrukne tabletter
sandoz a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 500.000 ie
pancillin 500.000 ie filmovertrukne tabletter
2care4 aps - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 500.000 ie
ospen 1 mill. ie filmovertrukne tabletter
paranova danmark a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie
pancillin 1,5 mill. ie filmovertrukne tabletter
abacus medicine a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1,5 mill. ie
pancillin 1 mill. ie filmovertrukne tabletter
abacus medicine a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie
penhexal 1 mill. ie filmovertrukne tabletter
nordic prime aps - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie
ospen 500.000 ie filmovertrukne tabletter
orifarm a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 500.000 ie
pancillin 1 mill. ie filmovertrukne tabletter
nordic prime aps - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiske midler - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
penhexal 1 mill. ie filmovertrukne tabletter
orifarm a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie